Sun Pharma ups offer for Taro Pharma to $43 per share in cash
Mint Mumbai|December 13, 2023
Sun Pharmaceutical Industries on Tuesday said it has revised upwards the price at which it proposed to fully acquire Israel-based Taro Pharmaceutical Industries to $43 per share in cash.
Sun Pharma ups offer for Taro Pharma to $43 per share in cash

In May this year, the company announced a non-binding indication of interest to acquire all of the outstanding ordinary shares of Taro for a purchase price of $38 per ordinary share in cash through a reverse triangular merger.

Diese Geschichte stammt aus der December 13, 2023-Ausgabe von Mint Mumbai.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

Diese Geschichte stammt aus der December 13, 2023-Ausgabe von Mint Mumbai.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

WEITERE ARTIKEL AUS MINT MUMBAIAlle anzeigen
Mint Mumbai

Aim for an efficient carbon market right from the start

India's economy is projected to grow dramatically over the next few decades. In nominal terms, it may double in size by 2030. This is exciting, but it comes with a significant risk.

time-read
3 Minuten  |
November 15, 2024
Mint Mumbai

Why health insurers refuse to cover certain treatments

While 12 modern treatments are covered, many advanced procedures are yet to be included

time-read
3 Minuten  |
November 15, 2024
Mint Mumbai

Address economic distress with structural reforms and not doles

Cash transfers may offer short-term relief but raising worker incomes is the only lasting solution

time-read
3 Minuten  |
November 15, 2024
Mint Mumbai

FUNDING FOREIGN EDUCATION: SHOULD YOU SAVE OR BORROW?

Education financing needs vary, but early planning is key to building your desired corpus

time-read
2 Minuten  |
November 15, 2024
WHICH BLOC'S POPULISM WILL WIN MAHARASHTRA?
Mint Mumbai

WHICH BLOC'S POPULISM WILL WIN MAHARASHTRA?

Both the ruling Mahayuti and opposition Maha Vikas Aghadi are dangling a slew of welfare schemes to woo the electorate

time-read
8 Minuten  |
November 15, 2024
Will my cured illness be eligible for coverage after three years?
Mint Mumbai

Will my cured illness be eligible for coverage after three years?

My health insurance policy started on 29 June 2022. I was treated for a disease in October 2016. The period between the treatment and the policy start date is over 56 months. As per regulations, pre-existing conditions are those diagnosed within 36 months of policy purchase date. I had a surgery on 29 August 2024. Will my claim for the latest surgery get reimbursed? - Name withheld on request

time-read
1 min  |
November 15, 2024
SECI barrels down on Reliance Power
Mint Mumbai

SECI barrels down on Reliance Power

SECI banned the power firm from its clean energy tenders for three years.

time-read
1 min  |
November 15, 2024
Mint Mumbai

Blackstone revises Haldiram's stake

Blackstone has dropped plans to acquire a majority stake in the snacks business of India's Haldiram's but is now discussing purchase of a 20% stake at a valuation of $8 billion, which is still a sticking point, people familiar with the matter said on Thursday.

time-read
1 min  |
November 15, 2024
Mint Mumbai

Delhivery reports ₹10.2 cr profit in Q2

Delhivery reported a net profit of ₹10.2 crore in the September quarter, against a loss posted a year ago.

time-read
1 min  |
November 15, 2024
Mint Mumbai

Muthoot Finance Q2 profit rises 26%

Gold loan provider Muthoot Finance reported a 26% rise in its second-quarter profit on Thursday, boosted by strong loan demand, and raised its gold loan growth forecast for the financial year 2025.

time-read
1 min  |
November 15, 2024